Pharmaceutical & Specialty Chemicals

European Pharmacopoeia–grade GABA analogue for anticonvulsant and neuropathic pain capsule formulations. Full impurity profile control to Ph.Eur standards for European regulated market supply.

IP pharmacopoeial–grade pregabalin for domestic and export capsule and oral solution formulations. Supplied with confirmed chiral purity, particle size, and dissolution performance data.

Benzimidazole proton pump inhibitor API for oral enteric-coated tablet formulations. Traded in refined crystalline grade with documented impurity profile and polymorph consistency.

HMG-CoA reductase inhibitor calcium salt API for oral tablet formulations. IP-grade with confirmed polymorphic form and low-dose tablet suitability for statin therapy supply.

Bacterial serine protease enzyme API in enteric-form used in anti-inflammatory tablet formulations. Traded in IP-grade with confirmed enzymatic potency (SPU/mg) per pharmacopoeial standards.

High-intensity sweetener (600× sucrose) for pharmaceutical and nutraceutical formulations requiring calorie-free sweetening. Supplied in standard purity grade for direct blending in oral dosage forms.

Beta-lactamase inhibitor sterile sodium salt API, dual pharmacopoeial–compliant (IP/USP) for injectable combination antibiotic formulations. Full sterility and endotoxin clearance documentation provided.

Beta-lactamase inhibitor API in sodium salt form for injectable combination antibiotic formulation manufacture. IP-grade with both sterile and non-sterile grades available for flexible supply.